Results 31 to 40 of about 41,109 (286)

Management of chronic primary pelvic pain syndromes

BJU International, 2021
Management of chronic pelvic pain (CPP) remains a huge challenge for care providers and a major burden for healthcare systems. Treating chronic pain that has no obvious cause warrants an understanding of the difficulties in managing these conditions. Chronic pain has recently been accepted as a disease in its own right by the World Health Organization,
Brian A. Parsons, Andrew P. Baranowski, Bary Berghmans, Jan Borovicka, Angela M. Cottrell, Paulo Dinis‐Oliveira, Sohier Elneil, John Hughes, Bert E. J. Messelink, Amanda C. de C Williams, Pedro Abreu‐Mendes, Valentin Zumstein, Daniel S. Engeler   +12 more
openaire   +4 more sources

Ningmitai capsules have anti-inflammatory and pain-relieving effects in the chronic prostatitis/chronic pelvic pain syndrome mouse model through systemic immunity

Frontiers in Pharmacology, 2022
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) seriously affects the physical and mental health of approximately 90% of males. Due to its complex and unclear etiology, the treatment methods that are currently available for chronic prostatitis/
Hanchao Liu, Zhenqing Wang, Qigen Xie, Qigen Xie, Ani Chi, Yanqing Li, Jian Dai, Min Zhang, Chunhua Deng, Guihua Liu   +9 more
doaj   +1 more source

Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain. [PDF]

PLoS ONE, 2013
The etiology of chronic prostatitis/chronic pelvic pain syndrome in men is unknown but may involve microbes and autoimmune mechanisms. We developed an infection model of chronic pelvic pain in NOD/ShiLtJ (NOD) mice with a clinical Escherichia coli ...
Marsha L Quick, Larry Wong, Soumi Mukherjee, Joseph D Done, Anthony J Schaeffer, Praveen Thumbikat   +5 more
doaj   +1 more source

Central pain processing in women with chronic pelvic pain syndrome [PDF]

, 2022
Chronic pelvic pain (CPP) is chronic or persistent pain perceived in structures related to the pelvis of either men or women. It is often associated with negative cognitive, behavioural, sexual, and emotional consequences as well as with symptoms ...
Szubert, Wojciech
core   +1 more source

Pharmacological treatment and regional anesthesia techniques for pain management after completion of both conservative and surgical treatment of endometriosis and pelvic adhesions in women with chronic pelvic pain as a mandated treatment strategy

Annals of Agricultural and Environmental Medicine, 2015
Introduction. Chronic pelvic pain syndrome occurs in 4–14% of women. Pain pathomechanism in this syndrome is complex, as it is common to observe the features of nociceptive, inflammatory, neuropathic and psychogenic pain.
Małgorzata Malec-Milewska, Bartosz Horosz, Agnieszka Sękowska, Iwona Kolęda, Dariusz Kosson, Grzegorz Jakiel   +5 more
doaj   +3 more sources

Immune mediators of chronic pelvic pain syndrome [PDF]

Nature Reviews Urology, 2014
The cause of chronic pelvic pain syndrome (CPPS) has yet to be established. Since the late 1980s, cytokine, chemokine, and immunological classification studies using human samples have focused on identifying biomarkers for CPPS, but no diagnostically beneficial biomarkers have been identified, and these studies have done little to deepen our ...
Stephen F, Murphy, Anthony J, Schaeffer, Praveen, Thumbikat   +2 more
openaire   +2 more sources

Treatment of chronic prostatitis/chronic pelvic pain syndrome [PDF]

International Journal of Antimicrobial Agents, 2008
Acceptance of the National Institutes of Health definition of Category III Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) and the development and validation of the Chronic Prostatitis Symptom Index has stimulated significant research into treatment of this condition. Evidence-based suggestions for treatment include the following.
openaire   +2 more sources

Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study [PDF]

, 2023
PURPOSE: Symptom heterogeneity in interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively termed urological chronic pelvic pain syndrome, has resulted in difficulty in defining appropriate clinical ...
Catherine S. Bradley, Harte, Steven E, Karl Kreder, Niloofar Afari, Farrar, John T, Kreder, Karl, Griffith, James W, Alisa J. Stephens-Shields, Bruce D. Naliboff, Clemens, J Quentin, H. Henry Lai, J. Quentin Clemens, Lai, H Henry, Naliboff, Bruce D, Robert Moldwin, Landis, J Richard, Quallich, Susan, Rodriguez, Larissa V, Gupta, Priyanka, Steven E. Harte, James W. Griffith, Moldwin, Robert, John T. Farrar, Priyanka Gupta, Susan Quallich, Siobhan Sutcliffe, Larissa V. Rodriguez, Sutcliffe, Siobhan, Bradley, Catherine S, Afari, Niloofar, J. Richard Landis, Stephens-Shields, Alisa J   +31 more
core   +1 more source

Management of chronic prostatitis/chronic pelvic pain syndrome

Canadian Urological Association Journal, 2018
1.7 (95% confidence interval [CI], 2.8 to 0.6), 1.1 (95% CI, 1.8 to 0.3), 1.4 (95% CI, 2.3 to 0.5), and 1.0 (95% CI, 1.8 to 0.2), respectively. Patients receiving -blockers or anti-inflammatory medications had a higher chance of favorable response compared with placebo, with pooled RRs of 1.6 (95% CI, 1.1-2.3) and 1.8 (95% CI, 1.2-2.6 ...
R Christopher, Doiron, J Curtis, Nickel
openaire   +3 more sources

Pain, Catastrophizing, and Depression in Chronic Prostatitis/Chronic Pelvic Pain Syndrome [PDF]

International Neurourology Journal, 2013
Persistent and disabling pain is the hallmark of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). However, disease severity (as measured by objective indexes such as those that use radiography or serology) is only marginally related to patients' reports of pain severity, and pain-related presentation can differ widely among individuals with ...
Jong Kyou Kwon, In Ho Chang
openaire   +3 more sources